DURGASIC TRANSDERMAL PATCH LINKED TO ORGAN FAILURE
Duragesic (fentanyl transdermal system), a time-release pain medication patch, has been linked to multiple organ failure in patients. A lawsuit was filed in December 2005 on behalf of a woman who suffered multiple organ failure and died while using the patch.
The Food and Drug Administration began investigating the safety of Duragesic in 2005 and issued a public health advisory in July 2005. Duragesic is manufactured by Pharmaceutica (Johnson & Johnson.) The particular organs affected by Duragesic have not been identified by Johnson & Johnson.
Duragesic is an analgesic, or pain reliever, prescribed to manage chronic, long-lasting pain. It contains the opiod fentanyl. It is a patch worn on the skin that periodically releases pain medication into the system. It may be prescribed to alleviate joint or back pain, or pain associated with cancer. It is generally used when the pain cannot be managed by less potent pain relievers.
Symptoms of a Duragesic overdose include:
-
shallow or labored breathing;
-
tiredness;
-
extreme sleepiness or sedation;
-
inability to think, talk, or walk normally;
-
confusion;
-
and dizziness.
If any symptoms are observed, a physician should be consulted immediately.
To protect against possible overdose, the drug should not be used to treat short-term pain, pain that is not constant, or for pain after an operation, and it should be prescribed at the lowest does needed for pain relief.
If
you or a member of your family has taken Duragesic, then you may qualify for a lawsuit
claim. Thousands of people have already
filed claims.
In
America today there are thousands of mass lawsuits and billions of dollars in unclaimed
monies available for victims. If you have
been wronged by a major corporation, you may
be entitled to compensation for treatments
and pain and suffering. |